HomeInsightsStock Comparison

Cohance Lifesciences Ltd vs Fermenta Biotech Ltd Stock Comparison

Cohance Lifesciences Ltd vs Fermenta Biotech Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Cohance Lifesciences Ltd is ₹ 1065 as of 22 Jul 12:09.
  • The P/E Ratio of Cohance Lifesciences Ltd changed from 8.1 on March 2020 to 57.3 on March 2024 . This represents a CAGR of 47.89% over 5 yearsThe P/E Ratio of Fermenta Biotech Ltd changed from 10.3 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Cohance Lifesciences Ltd changed from ₹ 2564 crore on March 2020 to ₹ 17223 crore on March 2024 . This represents a CAGR of 46.37% over 5 yearsThe Market Cap of Fermenta Biotech Ltd changed from ₹ 626.14 crore on March 2020 to ₹ 445.59 crore on March 2024 . This represents a CAGR of -6.58% over 5 years.
  • The revenue of Cohance Lifesciences Ltd for the Mar '25 is ₹ 412.59 crore as compare to the Dec '24 revenue of ₹ 322.86 crore. This represent the growth of 27.79% The revenue of Fermenta Biotech Ltd for the Mar '25 is ₹ 143.74 crore as compare to the Dec '24 revenue of ₹ 158.7 crore. This represent the decline of -9.43%.
  • The ebitda of Cohance Lifesciences Ltd for the Mar '25 is ₹ 84.13 crore as compare to the Dec '24 ebitda of ₹ 133.41 crore. This represent the decline of -36.94% The ebitda of Fermenta Biotech Ltd for the Mar '25 is ₹ 40.84 crore as compare to the Dec '24 ebitda of ₹ 55.5 crore. This represent the decline of -26.41%.
  • The net profit of Cohance Lifesciences Ltd changed from ₹ 120.59 crore to ₹ 38.73 crore over 8 quarters. This represents a CAGR of -43.33% The net profit of Fermenta Biotech Ltd changed from ₹ 2.21 crore to ₹ 33.32 crore over 8 quarters. This represents a CAGR of 288.29% .
  • The Dividend Payout of Cohance Lifesciences Ltd changed from 23.57 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Fermenta Biotech Ltd changed from 22.65 % on March 2020 to 10.78 % on March 2025 . This represents a CAGR of -11.64% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Cohance Lifesciences Ltd

  • Suven Pharmaceuticals Limited (SPL) is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors.
  • The Company's comprehensive services encompass- Custom Synthesis, Process R&D, Scale-Up, and Contract Manufacturing of intermediates, APIs, and formulations. Suven Pharmaceuticals Limited was incorporated on 6 November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.
  • The Company has established core competencies in cyanation and heterocyclic chemistry, covering pyrimidines, quinolones, thiazoles, and imidazoles.

About Fermenta Biotech Ltd

  • Fermenta Biotech Limited was formerly incorporated as 'Duphar-Interfran Limited' in May, 1951.
  • The Company name was changed to 'DIL Limited' in September, 2003 and later on, the name was further changed to 'Fermenta Biotech Limited' on October 17, 2019. The Company is engaged in the business of manufacturing and marketing of chemicals, bulk drugs, enzymes, pharmaceutical formulations and environmental solution products and renting and selling of properties.
  • The Company has strategic investments in subsidiaries primarily dealing in manufacturing and marketing bulk drugs. In the initial years, the company manufactured and sold toothpaste, anti-septic lotion and pharmaceutical specialities on a loan-licence basis.
  • It entered into collaborations with Philips-Duphar, Amsterdam (Solvay Duphar), and the Crookes Laboratories, London.

Cohance Lifesciences Ltd News Hub

News

Cohance Lifesciences to announce Quarterly Result

Cohance Lifesciences will hold a meeting of the Board of Directors of the Company on 13 Au...

Read more

28 Jun 2025 09:56

News

Cohance Lifesciences to hold AGM

Cohance Lifesciences announced that the 7th Annual General Meeting(AGM) of the company wil...

Read more

27 Jun 2025 15:41

News

Cohance Lifesciences' API Unit-IV clears USFDA inspection

Cohance Lifesciences has received the Establishment Inspection Report (EIR) from the Unite...

Read more

26 May 2025 08:46

News

Suven Pharmaceuticals allots 12.80 cr equity shares

Suven Pharmaceuticals has allotted 12,80,02,184 equity shares of the Company of face value...

Read more

09 May 2025 09:58

News

Suven Pharmaceuticals renamed as Cohance Lifesciences

Suven Pharmaceuticals announced that the Ministry of Corporate Affairs, Government of Indi...

Read more

08 May 2025 09:39

News

Suven Pharmaceuticals receives regulatory nod for scheme of amalgamation

Suven Pharmaceuticals announced that it has received final approval from the Department of...

Read more

26 Apr 2025 12:56

Fermenta Biotech Ltd News Hub

News

Fermenta Biotech schedules AGM

Fermenta Biotech announced that the Annual General Meeting(AGM) of the company will be hel...

Read more

29 May 2025 11:31

News

Board of Fermenta Biotech recommends final dividend

Fermenta Biotech announced that the Board of Directors of the Company at its meeting held ...

Read more

28 May 2025 18:28

News

Fermenta Biotech to convene board meeting

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 28 May 20...

Read more

22 May 2025 19:43

News

Fermenta Biotech announces board meeting date

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 11 Februa...

Read more

05 Feb 2025 11:26

News

Fermenta Biotech to discuss results

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 14 Novemb...

Read more

08 Nov 2024 17:02

News

Fermenta Biotech to discuss results

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 12 August...

Read more

07 Aug 2024 12:35

SWOT Analysis Of Fermenta Biotech Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Cohance Lifesciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Fermenta Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Cohance Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Cohance Lifesciences Ltd and Fermenta Biotech Ltd

Which company has a larger market capitalization, Cohance Lifesciences Ltd or Fermenta Biotech Ltd?

Market cap of Cohance Lifesciences Ltd is 40,988 Cr while Market cap of Fermenta Biotech Ltd is 1,116 Cr

What are the key factors driving the stock performance of Cohance Lifesciences Ltd and Fermenta Biotech Ltd?

The stock performance of Cohance Lifesciences Ltd and Fermenta Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cohance Lifesciences Ltd and Fermenta Biotech Ltd?

As of July 22, 2025, the Cohance Lifesciences Ltd stock price is INR ₹1071.4. On the other hand, Fermenta Biotech Ltd stock price is INR ₹379.4.

How do dividend payouts of Cohance Lifesciences Ltd and Fermenta Biotech Ltd compare?

To compare the dividend payouts of Cohance Lifesciences Ltd and Fermenta Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions